NCT04464213

Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer

Phase I Clinical Trials of Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 43 (estimated)
• Sponsor: Beijing Tongren Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is designated to: 1. investigate the tolerance and safety of treatment of Human placental mesenchymal stem cells gel on Human diabetic foot ulcer. 2. learn the primary effectiveness of Human placental mesenchymal stem cells gel on Human diabetic food ulcer. 3. study the pharmacokinetics of Human placental mesenchymal stem cells gel on Human diabetic food ulcer.

Conditions

• Diabetic Foot Ulcer

Interventions

Type	Name	Description
OTHER	Single dose experiments	In single dose experiments, after clean the diabetic foot ulcer, paint the Human placental mesenchymal stem cells gel on the wound, each patient only receive treatment once time.
OTHER	Multi-dose experiments	In multi-dose experiments, after clean the diabetic foot ulcer, paint the Human placental mesenchymal stem cells gel on the wound, each patient receive treatment on six consecutive days.

Timeline

• Start date: 2020-11-01
• Primary completion: 2023-08-01
• Completion: 2023-12-31
• First posted: 2020-07-09
• Last updated: 2022-10-21

Locations

1 site across 1 country: China